J1602 HCPCS code: Injection, golimumab, 1 mg, for intravenous use
J1602 is the HCPCS Level II code for injection, golimumab, 1 mg, for intravenous use. In 2024 Medicare paid an average of $8.99 per service for J1602 across 23,986,169 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 14% from 2022 to 2024 (20,960,842 to 23,986,169 services). In 2024, about 3,670 clinicians billed Medicare for J1602 for 28,225 beneficiaries; Texas, Florida, California accounted for 23% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2014-01-01 |
| Last action effective | 2014-01-01 |
Who bills J1602 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,670 |
| Medicare beneficiaries | 28,225 |
| States with claims | 51 |
| Share of services in top 3 states (Texas, Florida, California) | 23% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1602, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 20,960,842 | 25,084 | $14.63 | $11.63 |
| 2023 | 22,912,221 | 27,391 | $13.11 | $10.40 |
| 2024 | 23,986,169 | 28,225 | $11.35 | $8.99 |
States with the most J1602 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 2,079,694 | $8.96 |
| Florida | 2,010,050 | $9.03 |
| California | 1,451,486 | $9.04 |
| North Carolina | 1,409,252 | $9.00 |
| South Carolina | 1,203,198 | $8.94 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J1602
- 2014-01-01: J1602 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1602?
J1602 is the HCPCS Level II code for injection, golimumab, 1 mg, for intravenous use. Short descriptor: "Golimumab for iv use 1mg".
How much does Medicare pay for J1602?
In 2024, the average Medicare payment was $8.99 per service (average allowed $11.35).
Does Medicare cover J1602?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1602 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J16 codes
- J1600 — Injection, gold sodium thiomalate, up to 50 mg
- J1610 — Injection, glucagon hydrochloride, per 1 mg
- J1611 — Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612 — Injection, glucagon (gvoke), 0.01 mg
- J1620 — Injection, gonadorelin hydrochloride, per 100 mcg
- J1626 — Injection, granisetron hydrochloride, 100 mcg
- J1627 — Injection, granisetron, extended-release, 0.1 mg
- J1628 — Injection, guselkumab, 1 mg
- J1630 — Injection, haloperidol, up to 5 mg
- J1631 — Injection, haloperidol decanoate, per 50 mg
- J1632 — Injection, brexanolone, 1 mg
- J1640 — Injection, hemin, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1602
- Watch J1602 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1602
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.